Canandaigua National Trust Co of Florida Purchases Shares of 1,909 HCA Healthcare, Inc. (NYSE:HCA)

Canandaigua National Trust Co of Florida bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The firm bought 1,909 shares of the company's stock, valued at approximately $660,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare in the 1st quarter worth about $28,000. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth about $31,000. Bartlett & CO. Wealth Management LLC increased its stake in HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares in the last quarter. Tidemark LLC bought a new stake in HCA Healthcare during the 4th quarter valued at about $36,000. Finally, ORG Partners LLC increased its stake in HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Royal Bank Of Canada reiterated an "outperform" rating and issued a $404.00 price target (up from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Guggenheim began coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Robert W. Baird reiterated a "neutral" rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a "buy" rating to a "hold" rating in a report on Friday. Eight equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $395.71.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by insiders.

HCA Healthcare Trading Up 0.4%

Shares of HCA opened at $379.00 on Monday. The company's fifty day moving average is $366.55 and its 200 day moving average is $337.09. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market capitalization of $91.18 billion, a PE ratio of 16.85, a P/E/G ratio of 1.31 and a beta of 1.49. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business's revenue was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.36 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.